Influence of the surgical technique on survival in the treatment of carcinomas of the true cardia (Siewert Type II) - Right thoracoabdominal vs. transhiatal-abdominal approach.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
03 2019
Historique:
received: 16 04 2018
revised: 29 08 2018
accepted: 26 09 2018
pubmed: 7 11 2018
medline: 8 3 2019
entrez: 7 11 2018
Statut: ppublish

Résumé

It is still a matter of debate whether subtotal esophagectomy via a right thoracoabdominal approach (RTA) or extended gastrectomy using a transhiatal-abdominal approach (TH) is the favorable technique in the treatment of Siewert type II esophago-gastric junction adenocarcinoma (EJA). Patients undergoing RTA or TH for EJA at our institution between 2000 and 2013 were extracted from a prospective database. Of 270 patients 91 (33.7%) underwent RTA and 179 (66.3%) were treated by TH. Differences in baseline characteristics, 30d mortality and complications were investigated using the χ2-test or exact testing. Survival analysis was performed using the Kaplan-Meier method and log rank testing. Median survival and hazard ratios were calculated and multivariable analysis of predictors was performed using a Cox model. Confounders were balanced using propensity score matching (PSM). No significant difference between the two procedures was detected regarding overall-survival (OS) and disease-free survival (DFS). 30d mortality rates were 1.1% in the RTA group and 4.5% in the TH group (p = 0.134). Morbidity was 34.1% in the RTA and 24.6% in the TH group (p = 0.006). Cox regression analysis identified age, ASA class and UICC stage as independent prognostic factors for OS. After PSM survival curves (OS + PFS) showed no significant difference. The present study could not detect a difference between RTA and TH from the oncologic point of view; RTA was not associated with higher 30d mortality. RTA for Siewert Type II EJA is justified whenever the oral tumor margin cannot be safely reached via a transhiatal approach.

Identifiants

pubmed: 30396809
pii: S0748-7983(18)31436-7
doi: 10.1016/j.ejso.2018.09.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

416-424

Informations de copyright

Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Auteurs

C Tosolini (C)

Klinik und Poliklinik für Chirurgie, Klinikum Rechts der Isar der Technischen Universität München, Germany; Visceral- und Thoraxchirurgie, Kreisklinikum Erding, Germany.

D Reim (D)

Klinik und Poliklinik für Chirurgie, Klinikum Rechts der Isar der Technischen Universität München, Germany.

R Schirren (R)

Klinik und Poliklinik für Chirurgie, Klinikum Rechts der Isar der Technischen Universität München, Germany.

M Feith (M)

Klinik und Poliklinik für Chirurgie, Klinikum Rechts der Isar der Technischen Universität München, Germany.

H Friess (H)

Klinik und Poliklinik für Chirurgie, Klinikum Rechts der Isar der Technischen Universität München, Germany.

A R Novotny (AR)

Klinik und Poliklinik für Chirurgie, Klinikum Rechts der Isar der Technischen Universität München, Germany. Electronic address: alexander.novotny@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH